Category Archives: Pr Newswire

TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis

Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility Analysis SYDNEY, AUSTRALIA, March 13, 2026 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), today announced that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa (“efti”) in patients in 1st line […]

Former JP Morgan and Dresdner Kleinwort Traders Launch Crypto Prop Firm After Paying Out USD2.5 Billion in Fintech

*Velotrade enters the crypto funded trading market with institutional foundations, aligned incentives, and a rule set built from scratch for crypto traders* HONG KONG, March 13, 2026 /PRNewswire/ — Velotrade, founded by former institutional derivatives traders from JP Morgan, Dresdner Kleinwort, and Bank of America, today announced the launch of its crypto funded trading platform. The […]

YY Group Welcomes The Landmark Bangkok to Growing Hospitality Client Portfolio

New Manpower Outsourcing Contract Advances Subsidiary YY Circle Thailand’s Path to Meaningful Scale, Adds to 2026 Revenue Visibility SINGAPORE, March 13, 2026 /PRNewswire/ — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that its Thailand subsidiary, YY Circle […]

ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems

NUREMBERG, Germany, March 13, 2026 /PRNewswire/ — As embedded world 2026 concludes in Nuremberg, one theme stands out across the exhibition halls: the rapid acceleration of intelligent edge systems. With the convergence of high-performance computing, on-device AI, and industry-specific software platforms, enterprises are increasingly shifting intelligence from the cloud to the edge to enable real-time […]

Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy

SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This breakthrough marks UX-GIP001 as the first iPSC-derived allogeneic epilepsy cell therapy approved in the U.S. and […]

XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026

CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ — XtalPi Holdings Limited (“XtalPi”, or the “Company”) (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced that it will report its annual results for the full year ended December 31, 2025 on Wednesday, March 25, 2026, after […]

YEEDI Launches M16 Infinity, an Award-Winning Robot Vacuum Built on the Success of the M14 PLUS

SAN FRANCISCO, March 13, 2026 /PRNewswire/ — YEEDI today announced the launch of the M16 Infinity, a next-generation robot vacuum designed to deliver stronger cleaning performance, quieter operation, and easier maintenance. M16 Infinity The launch builds on the success of the YEEDI M14 PLUS, a model widely recognized by both reviewers and consumers. The M14 PLUS […]

KuCoin Launches Stock Index Perpetual Contracts, Expanding 24/7 Cross-Asset Access

PROVIDENCIALES, Turks and Caicos Islands, March 13, 2026 /PRNewswire/ — KuCoin, a leading global crypto platform built on trust, today announced the launch of its Stock Index Perpetual Contracts, with the first batch of contracts scheduled for listing, including Tesla Index Perpetual Contract (TSLAUSDT) and MicroStrategy Index Perpetual Contract (MSTRUSDT). As traditional finance (TradFi) and […]

Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 0.625% convertible senior notes due 2031 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act […]

VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) — Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that it has updated the date for the release of its financial results for the fourth quarter and year ended December 31, 2025. The Company now expects to release its financial results on Wednesday, March 18, 2026, after […]